BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24692843)

  • 1. Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma.
    Lucarelli G; Ditonno P; Bettocchi C; Vavallo A; Rutigliano M; Galleggiante V; Larocca AM; Castellano G; Gesualdo L; Grandaliano G; Selvaggi FP; Battaglia M
    Dis Markers; 2014; 2014():689795. PubMed ID: 24692843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
    Spachmann PJ; Breyer J; Kalogirou C; Lausenmeyer EM; Weber F; Prohaska S; Denzinger S; Burger M; Kübler H; Otto W; Vergho D
    Urol Int; 2019; 102(4):413-420. PubMed ID: 30844790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma.
    Gigante M; Lucarelli G; Divella C; Netti GS; Pontrelli P; Cafiero C; Grandaliano G; Castellano G; Rutigliano M; Stallone G; Bettocchi C; Ditonno P; Gesualdo L; Battaglia M; Ranieri E
    Medicine (Baltimore); 2015 Nov; 94(45):e1917. PubMed ID: 26559258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic model for patients with sarcomatoid renal cell carcinoma.
    Zhang BY; Thompson RH; Lohse CM; Leibovich BC; Boorjian SA; Cheville JC; Costello BA
    BJU Int; 2015 Mar; 115(3):405-11. PubMed ID: 24730416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased preoperative levels of plasma fibrinogen and D dimer in patients with renal cell carcinoma is associated with poor survival and adverse tumor characteristics.
    Erdem S; Amasyali AS; Aytac O; Onem K; Issever H; Sanli O
    Urol Oncol; 2014 Oct; 32(7):1031-40. PubMed ID: 25027687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection.
    Lee HW; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    J Korean Med Sci; 2015 Sep; 30(9):1321-7. PubMed ID: 26339174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma.
    Grankvist K; Ljungberg B; Rasmuson T
    Int J Cancer; 1997 Apr; 74(2):233-6. PubMed ID: 9133462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations.
    Qin C; Sun LJ; Cui L; Cao Q; Zhu J; Li P; Zhang GM; Mao X; Shao PF; Wang ML; Zhang ZD; Gu M; Zhang W; Yin CJ
    Asian J Androl; 2013 Jul; 15(4):550-7. PubMed ID: 23564046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.
    Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    Int J Clin Oncol; 2018 Feb; 23(1):142-150. PubMed ID: 28791497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.
    Obata J; Tanaka N; Mizuno R; Kanao K; Mikami S; Matsumoto K; Kosaka T; Kikuchi E; Jinzaki M; Oya M
    BJU Int; 2016 Oct; 118(4):598-603. PubMed ID: 26780664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    J Korean Med Sci; 2016 Dec; 31(12):1976-1982. PubMed ID: 27822938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
    Hutterer GC; Stoeckigt C; Stojakovic T; Jesche J; Eberhard K; Pummer K; Zigeuner R; Pichler M
    Urol Oncol; 2014 Oct; 32(7):1041-8. PubMed ID: 25027686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma.
    Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N
    BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.